# ğŸ§¬ MTB-Illumina-WGS-Analysis  

![GitHub last commit](https://img.shields.io/github/last-commit/betselotz/MTB-Illumina-WGS-Analysis)  

Bioinformatics workflow for analyzing *Mycobacterium tuberculosis* whole-genome sequences (WGS) generated by Illumina and available on NCBI.  

---  

Written by: [**Betselot Zerihun Ayano**](https://github.com/betselotz)  

---  

## Introduction â€“ *Mycobacterium tuberculosis* Complex (MTBC)  

<details>
  <summary>ğŸ¦  MTBC & TB Genomics Overview</summary>

- **ğŸ§¬ Mycobacterium tuberculosis complex (MTBC):** Closely related species causing TB in humans & animals.  
- **ğŸŒ Global Impact:** TB remains a leading cause of infectious disease morbidity & mortality.  
- **ğŸ”’ Highly Clonal Genome:** Limited horizontal gene transfer â†’ genomic analysis critical for evolution, transmission & drug resistance.  
- **ğŸ“ Genome Size:** ~4.4 Mbp  
- **ğŸ’ GC Content:** ~65%  
- **ğŸ” Comparative Genomics:** Identifies lineage-specific SNPs, large sequence polymorphisms (LSPs), and regions of difference (RDs) â†’ useful for strain typing & epidemiology.  
- **ğŸ’» Whole-Genome Sequencing (WGS) Enables:**  
  - ğŸ’Š Detect drug-resistance mutations (e.g., *rpoB*, *katG*, *inhA*)  
  - ğŸŒ³ Phylogenetic analysis to trace transmission & outbreaks  
  - ğŸ§© Detect genomic diversity & microevolution within hosts/populations  
- **ğŸ¥ Public Health Impact:** MTBC genomics informs molecular surveillance, outbreak investigation, and personalized TB treatment.

</details>

---  

### MTBC Species  
<details>
  <summary>ğŸ¦  MTBC Species Overview</summary>

The **Mycobacterium tuberculosis complex (MTBC)** consists of several genetically related species that cause tuberculosis in humans and animals:  

- ğŸ§ **Mycobacterium tuberculosis** â€“ the primary human pathogen; responsible for the majority of TB cases globally; primarily infects the lungs but can cause extrapulmonary TB.  
- ğŸ„ **Mycobacterium bovis** â€“ mainly infects cattle; can cause zoonotic TB in humans through unpasteurized dairy or close contact; used in BCG vaccine derivation.  
- ğŸŒ **Mycobacterium africanum** â€“ largely restricted to West Africa; causes human TB; less virulent than *M. tuberculosis*, but important regionally.  
- ğŸŒ¿ **Mycobacterium canettii** â€“ rare; mostly reported in East Africa; considered ancestral-like, showing higher genetic diversity; primarily human infections.  
- ğŸ€ **Mycobacterium microti** â€“ primarily infects wild rodents (voles); occasionally causes TB in humans; used in some experimental TB models.  
- ğŸ¦­ **Mycobacterium pinnipedii** â€“ infects seals and other pinnipeds; zoonotic infections are rare in humans.  
- ğŸ **Mycobacterium caprae** â€“ mainly infects goats and other livestock; can occasionally infect humans; prevalent in parts of Europe.  
- ğŸ– **Mycobacterium orygis** â€“ infects various wild and domestic animals including antelopes, cattle, and occasionally humans; mainly reported in South Asia.  
- ğŸ‚ **Mycobacterium mungi** â€“ infects banded mongooses in Africa; causes wildlife TB; rare human relevance.  
- ğŸ˜ **Mycobacterium suricattae** â€“ infects meerkats in Southern Africa; wildlife pathogen with ecological importance.  
- ğŸ **Mycobacterium caprae-like strains** â€“ occasionally distinguished in livestock or wildlife; emphasizes host-adapted diversity within MTBC.  

These species differ in **host preference, geographic distribution, virulence, and zoonotic potential**, highlighting the importance of genomic surveillance and comparative studies for TB control.  

</details>

---  

### *M. tuberculosis* Lineages  

<details>
  <summary>ğŸŒ MTBC Lineages Overview</summary>

Genomic studies have identified **10 major lineages** of MTBC based on SNPs, large sequence polymorphisms (LSPs), and phylogeny. These lineages show differences in **geographic distribution, host adaptation, virulence, and drug-resistance association**:  

1. ğŸŸ¢ **Lineage 1 (Indo-Oceanic / EAI â€“ East African-Indian)** â€“ Predominantly found in East Africa, India, and Southeast Asia; associated with slow progression of disease in some regions.  
2. ğŸ”´ **Lineage 2 (East-Asian / Beijing)** â€“ Widespread in East Asia and parts of Russia; often associated with multidrug resistance and high virulence.  
3. ğŸ”µ **Lineage 3 (East-African-Indian / CAS â€“ Central Asian Strain)** â€“ Found in South Asia and East Africa; linked to moderate transmission and some drug-resistance profiles.  
4. ğŸŸ¡ **Lineage 4 (Euro-American / LAM, Haarlem, X-type, T-type)** â€“ Globally widespread; highly successful in transmission; includes multiple sublineages.  
5. ğŸŸ£ **Lineage 5 (West African 1 / *M. africanum* type 1)** â€“ Mostly restricted to West Africa; slower progression of TB; less virulent than L4.  
6. ğŸŸ¤ **Lineage 6 (West African 2 / *M. africanum* type 2)** â€“ West Africa; similar epidemiology to Lineage 5; historically associated with specific ethnic populations.  
7. ğŸŸ  **Lineage 7** â€“ Restricted to Ethiopia; ancient lineage with unique SNP markers; less studied, may have local host adaptation.  
8. ğŸŸ£ **Lineage 8** â€“ Discovered in Rwanda and Uganda; deep-branching, highly ancestral; limited prevalence, provides insight into MTBC evolution.  
9. âš« **Lineage 9** â€“ Identified in East Africa; rare; distinct SNP profile; contributes to regional TB genetic diversity.  
10. âšª **Lineage 10** â€“ Recently reported in East/Central Africa; very limited information; potentially ancestral lineage with unique genomic characteristics.  

> Understanding MTBC species and lineages is critical for **epidemiology, phylogenetics, outbreak tracing, and drug-resistance surveillance**, as different lineages can show varying transmission dynamics and treatment outcomes.

</details>

---  

### *Mycobacterium tuberculosis* Sublineages  

<details>
  <summary>ğŸ” MTBC Sublineages</summary>
*M. tuberculosis* lineages are further divided into **sublineages** based on phylogenetic SNP markers, large sequence polymorphisms, and other genomic signatures. Sublineages reflect **microevolution, genomic diversity, and lineage-specific traits**:  

- ğŸŸ¢ **Lineage 1 (Indo-Oceanic / EAI â€“ East African-Indian):**  
  - Sublineages: L1.1, L1.2, L1.3  
  - Also called â€œEast African-Indianâ€ sublineages  
  - Show differences in SNP density, virulence markers, and drug-resistance loci  
- ğŸ”´ **Lineage 2 (East-Asian / Beijing):**  
  - Sublineages: L2.1 (Proto-Beijing), L2.2 (Modern Beijing), L2.2.1, L2.2.2  
  - â€œBeijingâ€ sublineages have distinct genomic deletions, IS6110 insertion patterns, and higher mutation rates contributing to drug resistance  
- ğŸ”µ **Lineage 3 (East-African-Indian / CAS â€“ Central Asian Strain):**  
  - Sublineages: L3.1, L3.2, L3.3  
  - Also called â€œCASâ€ strains  
  - Genomic variation includes lineage-specific SNPs and polymorphic loci influencing host-pathogen interactions  
- ğŸŸ¡ **Lineage 4 (Euro-American / LAM, Haarlem, X-type, T-type):**  
  - Sublineages: L4.1â€“L4.10 (includes LAM, Haarlem, X-type, T-type sublineages)  
  - Exhibits high genomic diversity, including large sequence polymorphisms (LSPs) and sublineage-specific SNP clusters  
  - Provides resolution for fine-scale phylogenetic studies and outbreak tracing  
- ğŸŸ£ **Lineage 5 (West African 1 / *M. africanum* type 1):**  
  - Sublineages: L5.1, L5.2 (where described)  
  - Genomic differences include lineage-specific SNPs and regions of difference (RDs)  
  - Less virulent than Lineage 4, with specific adaptation markers  
- ğŸŸ¤ **Lineage 6 (West African 2 / *M. africanum* type 2):**  
  - Sublineages: L6.1, L6.2 (limited description)  
  - Distinct SNP patterns and genomic deletions separate it from L5  
  - Important for studying regional adaptation and genomic evolution  
- ğŸŸ  **Lineage 7:**  
  - Ancient lineage restricted to Ethiopia  
  - Unique SNP markers and genomic signatures distinguish it from other lineages  
  - Limited sublineage information due to low prevalence  
- ğŸŸ¡ **Lineage 8:**  
  - Deep-branching, recently discovered in Rwanda and Uganda  
  - Shows ancestral genomic characteristics  
  - Genomic diversity includes lineage-specific SNPs and RDs  
- âš« **Lineage 9:**  
  - Rare, identified in East Africa  
  - Distinct SNP profile, showing microevolutionary divergence from other lineages  
  - Limited sublineage information  
- âšª **Lineage 10:**  
  - Recently reported in East/Central Africa  
  - Genomic features are ancestral with unique SNP and RD patterns  
  - Very limited prevalence; data still emerging  
> Sublineages capture **microevolutionary changes, genomic diversity, and lineage-specific features**, making them essential for high-resolution phylogenetics, drug-resistance studies, and molecular epidemiology.  

</details>


---  

### *Mycobacterium tuberculosis* Drug-Resistance Types  
<details>
  <summary>ğŸ’Š TB Drug-Resistance Definitions</summary>

| Abbreviation | Full Name | Description |
|-------------|-----------|-------------|
| **HR-TB** | Isoniazid-Resistant TB | Resistant to **isoniazid** but susceptible to **rifampicin**, with or without resistance to other drugs |
| **RR-TB** | Rifampicin-Resistant TB | Resistant to **rifampicin**, with or without resistance to other drugs |
| **MDR-TB** | Multidrug-Resistant TB | Resistant to **both isoniazid and rifampicin** |
| **Pre-XDR-TB** | Pre-Extensively Drug-Resistant TB | MDR TB + resistance to **fluoroquinolone** or **second-line injectable** |
| **XDR-TB** | Extensively Drug-Resistant TB | MDR TB + resistance to **fluoroquinolone** + **injectable** |
| **Other** | Other Drug-Resistance Patterns | Includes mono-resistant TB, poly-resistant TB, and rare profiles |

> Understanding these resistance patterns is crucial for **treatment decisions and epidemiological surveillance**.

</details>

---  

### Drug-Resistance Mutations  

<details>
  <summary>ğŸ§¬ Key TB Drug-Resistance Mutations</summary>

- **Rifampicin:** *rpoB* mutations (e.g., S450L)  
- **Isoniazid:** *katG* (S315T), *inhA* promoter mutations  
- **Ethambutol:** *embB* (M306V/I)  
- **Pyrazinamide:** *pncA* mutations  
- **Fluoroquinolones:** *gyrA/gyrB* mutations  

> Mutations are catalogued and updated by the **World Health Organization (WHO)** for standardized drug-resistance interpretation.

</details>

- **Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance, 2nd ed (2023):**  
  [WHO TB Mutation Catalogue 2023](https://github.com/GTB-tbsequencing/mutation-catalogue-2023/tree/main/Final%20Result%20Files)  

---  


